ADMA Biologics Inc (NASDAQ: ADMA) stock enjoyed a major increase of 10.2% on 3/19/25. The shares closed at $20.61. Moreover, trading volume in this advance was exceptionally high at 214% of normal. The stock has […]
Xunlei Ltd (NASDAQ: XNET) stock closed at $5.11 on 3/19/25 after a major increase of 14.1%. This advance was accompanied by normal trading volume. Relative to the market the stock has been exceptionally strong over […]
Five Below Inc (NASDAQ: FIVE) has reported earnings for its fourth fiscal quarter (ending January 31) of $3.41 versus $3.66 for the same period a year ago — a decline of -7%. For the latest […]
Puma Biotechnology Inc (NASDAQ: PBYI) suffers from meaningful negative changes in fundamentals: the consensus estimate for December, 2025 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2026 decreased significantly. Puma […]
Extremely significant negative changes in Lakeland Industries Inc (NASDAQ: LAKE) investment behavior have recently occurred: its longer term price trend turned down, the stock fell on very heavy volume, and negative upside/downside volume developed. Recent […]
HealthEquity Inc (NASDAQ: HQY) stock closed at $84.32 on 3/19/25 after a major decline of -17.1%. Moreover, exceptionally high trading volume at 701% of normal accompanied the decline. The stock has been exceptionally strong relative […]
Semler Scientific Inc (NASDAQ: SMLR) stock enjoyed a major increase of 12.8% on 3/19/25. The shares closed at $40.04. Moreover, this advance was accompanied by above average trading volume at 122% of normal. The stock […]
HealthEquity Inc (NASDAQ: HQY) has reported earnings for its fourth fiscal quarter (ending January 31) of $0.30 versus $0.31 for the same period a year ago — a decline of -3%. For the latest four […]
Euroseas Ltd (NASDAQ: ESEA) stock closed at $29.84 on 3/18/25 after a major decline of -11.3%. Moreover, this decline was accompanied by exceptionally high trading volume at 216% of normal. The stock has been weak […]
Catalyst Biosciences Inc (NASDAQ: GYRE) stock closed at $8.57 on 3/18/25 after a major decline of -30.2%. Moreover, trading volume in this decline was exceptionally high at 812% of normal. The stock has declined -17.0% […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research